Endocrine aspects and sequel in patients with craniopharyngioma
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
A craniopharyngioma (CP) is an embryonic malformation of the sellar and parasellar region. The annual incidence is 0.5–2.0 cases/million per year and approximately 60% of CP is seen in adulthood. The therapy of choice is surgery, followed by cranial radiotherapy in about half of the patients. Typical initial manifestations at diagnosis in children are symptoms of elevated intracranial pressure, visual disturbances and hypopituitarism. CPs have the highest mortality of all pituitary tumours. The standardised overall mortality rate varies from 2.88 to 9.28 in cohort studies. Adults with CP have a 3–19-fold higher cardiovascular mortality in comparison to the general population. Women with CP have an even higher risk. The long-term morbidity is substantial with hypopituitarism, increased cardiovascular risk, hypothalamic damage, visual and neurological deficits, reduced bone health and reduction in quality of life and cognitive function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“This gender difference has also been shown among patients with hypopituitarism of any cause (6, 15, 16), where mortality from cerebrovascular disorders was particularly enhanced.”
BackgroundMolitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up
Karavitaki, N., Brufani, C., Warner, J. T., Adams, C. B. T., Richards, P., Ansorge, O., Shine, B., Turner, H. E., & Wass, J. A. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02231.x · Cited by 633 · cited 7×
“Problems with concentration, memory and executive function potentially affecting professional occupation and school performance have received more attention in recent years (8, 9, 14, 62).”
BackgroundInfluentialIncreased cerebrovascular mortality in patients with hypopituitarism
Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C., & Erfurth, E. M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1749.x · Cited by 542
Self-citationKaravitaki, N., Cudlip, S., Adams, C. B. T., & Wass, J. A. H. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0002 · Cited by 514
Premature Mortality in Patients with Addison’s Disease: A Population-Based Study
Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490 · cited 1×
“Furthermore, it has been shown that too high substitution doses of cortisone is associated with increased cardiovascular mortality in patients with acromegaly (24).”
BackgroundMorbidity and mortality in patients with craniopharyngioma after surgery
Crowley, R. K., Hamnvik, O. P., O’Sullivan, E. P., Behan, L. A., Smith, D., Agha, A., & Thompson, C. J. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03838.x · Cited by 108 · cited 5×
“In the Irish cohort, a subgroup of the GH deficient CP patients were offered GH therapy, but data did not show any survival benefit from GH treatment (10).”
BackgroundInfluentialBone density in young patients with congenital adrenal hyperplasia
Mora, S., Saggion, F., Russo, G., Weber, G., Bellini, A., Prinster, C., & Chiumello, G. (1996) · Bone · doi:10.1016/8756-3282(96)00003-8 · Cited by 95 · cited 13×
“Glucocorticoid-induced osteoporosis is well known (54), but long-term glucocorticoid replacement is not reported to affect BMD (55).”
BackgroundInfluentialCrowley, R. K., Woods, C., Fleming, M., Rogers, B., Behan, L. A., O’Sullivan, E. P., Kane, T., Agha, A., Smith, D., Costello, R. W., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.03993.x · Cited by 50
Cardiac risk after craniopharyngioma therapy
Mong, S., Pomeroy, S. L., Cecchin, F., Juraszek, A., & Alexander, M. E. (2008) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.11.007 · Cited by 34
Cited by
Treatment of Hypothalamic Obesity With GLP-1 Analogs
Dimitri, P., & Roth, C. L. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae200 · Cited by 25
Hinton, E. C., Lithander, F. E., Elsworth, R. L., Hawton, K., Narayan, K., Szymkowiak, S., Bedford, H. L., Naeem, N., Elson, R., Taylor-Miller, T., et al. (2024) · Hormone Research in Paediatrics · doi:10.1159/000530863 · Cited by 12
“Obesity in childhood craniopharyngioma is associated with a high risk of multisystem morbidity [10, 11], metabolic syndrome [12], cardiovascular disease [13], and mortality [14].”
Background
Metadata
- Authors
- Erfurth, E. M.
- Venue
- Journal of Pediatric Endocrinology and Metabolism
- Publisher
- Walter de Gruyter GmbH
- Published
- 2015-01-01
- Volume
- 28
- Issue
- 1-2
- Pages
- 19-26
- ISSN
- 0334-018X (ISSN-L)
- 2191-0251
- OpenAlex
- W2036855173
- Cited by
- 40
- References
- 11
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endocrine aspects and sequel in patients with craniopharyngioma. https://app.cochat.ai/papers/10.1515/jpem-2014-0419
- The paper
- Erfurth, E. M. (2015). Endocrine aspects and sequel in patients with craniopharyngioma. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2014-0419
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.